Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.

To investigate numerical aberrations of chromosome 17 and the p53 locus in early stages of hepatocellular carcinoma (HCC), 12 fresh-frozen specimens of small HCCs (less than 30 mm in size) were examined by dual-color fluorescence in situ hybridization. We used a chromosome 17 alpha-satellite DNA probe and a p53 locus-specific DNA probe. We also performed immunohistochemical analysis for p53 protein in the same cases. Gain of chromosome 17 was the most frequently observed anomaly, present in 58% of cases, and deletion of the p53 locus was observed in 50% of cases. The combination of chromosome 17 gain and p53 locus deletion was observed in 33.3% of cases. However, overexpression of p53 protein was not observed in any specimens. Our results suggest that gain of chromosome 17 and deletion of the p53 locus could represent early genetic events, prior to overexpression of p53 protein due to mutation, in early stage HCC.

[1]  Y. Tagawa,et al.  Analysis of p53 gene deletions in colorectal cancers using fluorescence in situ hybridization , 1997, Surgery Today.

[2]  Y. Tagawa,et al.  Quantitative analysis of numerical chromosome aberrations in various morphological types of colorectal carcinomas , 1996, Journal of Gastroenterology.

[3]  D. Catovsky,et al.  Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. , 2003, Haematologica.

[4]  J. Trent,et al.  The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. , 1999, Cancer research.

[5]  M. Emi,et al.  Identification of a 1‐cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma , 1999, Genes, chromosomes & cancer.

[6]  K. Okita,et al.  Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features , 1999, Hepatology.

[7]  Y. Tagawa,et al.  Higher frequencies of numerical aberrations of chromosome 17 in primary gastric cancers are associated with lymph node metastasis , 1999, Journal of Gastroenterology.

[8]  N. Wong,et al.  Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. , 1999, The American journal of pathology.

[9]  Y. Tagawa,et al.  Chromosome instability evaluated by fluorescence in situ hybridization in hereditary non-polyposis colorectal cancer , 1998, Journal of Gastroenterology.

[10]  M. Fiegl,et al.  Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. , 1998, Blood.

[11]  Hoguen Kim,et al.  Allelotype analysis of hepatocellular carcinoma , 1998, International journal of cancer.

[12]  C. Kainz,et al.  Numerical Chromosomal Aberrations in Borderline, Benign, and Malignant Epithelial Tumors of the Ovary: Correlation With p53 Protein Overexpression and Ki-67 , 1997, The Journal of the Society for Gynecologic Investigation: JSGI.

[13]  M. Buendia,et al.  Comprehensive allelotyping of human hepatocellular carcinoma , 1997, Oncogene.

[14]  M. Kobayashi,et al.  Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. , 1996, The American journal of pathology.

[15]  A. Bernheim,et al.  Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization , 1996, Hepatology.

[16]  T. Nakajima,et al.  Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome‐specific DNA probe , 1996, Cancer.

[17]  J. Gray,et al.  Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  T. Hanafusa,et al.  Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma , 1995, Journal of gastroenterology and hepatology.

[19]  F. Imazeki,et al.  p53 gene mutations and 17p allelic deletions in hepatocellular Carcinoma from Japan , 1993, Cancer.

[20]  N. Nishida,et al.  Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma , 1992, International journal of cancer.

[21]  T. Ishikawa,et al.  Allelotype study of primary hepatocellular carcinoma. , 1991, Cancer research.

[22]  H. Willard,et al.  Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. , 1988, Cancer research.